Overview
Non-Invasive Prenatal Testing
NIPT is a non-invasive prenatal test that uses a simple maternal blood sample to screen for chromosomal conditions in the developing baby. It analyzes cell-free fetal DNA in the mother’s bloodstream, and correctly identifies more than 99% of Down syndrome cases — traditional blood tests can miss as many as 15% — with a false-positive rate below 0.1%.
It needs a single blood draw from 11 weeks of pregnancy onwards, can be used in twin and IVF pregnancies, and results are ready in 7–10 business days. Choose the test that fits your needs below; each lists its price.
Choose Your Test
NIPT Test Options
Three non-invasive prenatal screens, from the essential chromosomal conditions to an extended panel. All need a single maternal blood sample.
Unity Basic — US$450
Trisomies 21, 18 and 13, sex chromosome aneuploidy, twin zygosity and 22q11.2 microdeletion, plus the baby’s RhD status for Rh-negative mothers.
View details →Unity Complete — US$800
Everything in Unity Basic, plus screening of your baby’s risk for inherited conditions such as cystic fibrosis, spinal muscular atrophy, sickle cell disease and Fragile X.
View details →Verify Plus (Illumina) — US$550
The common trisomies and sex chromosome conditions, aneuploidies of all chromosomes, and the 22q11.2, Prader-Willi, Angelman, Cri du chat, 1p36 and Wolf-Hirschhorn microdeletions.
View details →What NIPT Screens For
- Down Syndrome (Trisomy 21)
- Edwards Syndrome (Trisomy 18)
- Patau Syndrome (Trisomy 13)
- Optional: X & Y Sex Chromosomes
Why Choose NIPT?
- Non-invasive — simple blood draw, no procedure risk
- Available from 11 weeks of pregnancy
- Identifies more than 99% of Down syndrome cases
- False-positive rate below 0.1% — less need for amniocentesis
Important Note
NIPT is a screening test, not a diagnostic test. A positive result must be confirmed with a diagnostic test — CARIGEN’s QSTR Trisomy Analysis on a CVS or amniotic fluid sample. Discuss results with your doctor or genetic counsellor.